EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case T-695/21: Order of the General Court of 13 April 2022 — Alauzun and Others v Commission (Action for annulment and for failure to act — Public health — Medicinal products for human use — Conditional marketing authorisation for mRNA-technology vaccines — Lack of carcinogenicity and genotoxicity studies — Time limit for bringing proceedings — Delay — No invitation to act — Position taken — No interest in bringing proceedings — Lack of direct concern — Lack of individual concern — Inadmissibility — Request for the Court to issue directions — Lack of jurisdiction)

ECLI:EU:UNKNOWN:62021TB0695

62021TB0695

April 13, 2022
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

25.7.2022

Official Journal of the European Union

C 284/41

(Case T-695/21) (<span class="oj-super oj-note-tag">1</span>)

(Action for annulment and for failure to act - Public health - Medicinal products for human use - Conditional marketing authorisation for mRNA-technology vaccines - Lack of carcinogenicity and genotoxicity studies - Time limit for bringing proceedings - Delay - No invitation to act - Position taken - No interest in bringing proceedings - Lack of direct concern - Lack of individual concern - Inadmissibility - Request for the Court to issue directions - Lack of jurisdiction)

(2022/C 284/56)

Language of the case: French

Parties

Applicants: Virginie Alauzun (Saint Cannat, France) and the 773 other applicants whose names are listed in the annex to the order (represented by: F. Di Vizio, lawyer)

Defendant: European Commission (represented by: G. Gattinara and L. Haasbeek, acting as Agents)

Re:

By their action under Articles 263, 265 and 266 TFEU, the applicants ask the General Court (i) to declare that the European Commission unlawfully failed to include carcinogenicity and genotoxicity testing in the preclinical phase during the procedure granting the conditional marketing authorisation to mRNA-technology vaccines, (ii) to order the Commission to include such testing in past and future EMA procedures and (iii) to request the EMA to communicate certain information relating to that testing.

Operative part of the order

1.The action is dismissed as inadmissible.

2.There is no longer any need to adjudicate on the application for leave to intervene submitted by Moderna Biotech Spain SL.

3.Ms Virginie Alauzun and the other applicants whose names are included in the annex shall bear their own costs and pay those incurred by the European Commission.

4.Moderna Biotech Spain shall bear its own costs relating to the application to intervene.

(<span class="oj-super">1</span>) OJ C 2, 3.1.2022

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia